secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOVIE INC. (BIVI)
CIK:        0001580149
Form:       8-K
Filed at:   2022-07-15T23:59:59+00:00
Accession:  0001520138-22-000305
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioVie raises $6M in private placement with controlling stockholder Acuitas Group
--------------------------------------------------------------------------------

- Sale of 3,636,364 shares at $1.65 plus warrant for 7,272,728 shares at $1.82 for aggregate $6M.
- Closing expected August 15, 2022; net proceeds used for working capital.
- Oppenheimer & Co. acted as sole placement agent with 3% cash fee.
- Acuitas is 100% owned by chairman Terren Peizer; related-party transaction.
- Existing Registration Rights Agreement to be amended to cover PIPE shares and warrant shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1580149/000152013822000305/0001520138-22-000305-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1580149/000152013822000305/bivi-20220715_8k.htm
  HTML page:      https://secwatch.observer/filing/0001520138-22-000305

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer